← DSP Mutual Fund

DSP Nifty Healthcare ETF

Index/ETF Data as of Apr 2026 Comparing Mar 2026 → Apr 2026
Share: WhatsApp X
Stocks Held
20
Apr 2026
Equity Holdings
₹13.57 Cr
Equity only, excl. debt & cash
Top 5 Weight
50.5%
High concentration
Top 10 Weight
76.8%
High concentration
Changes
20
0 new · 0 exits
Top Sector
Pharmaceuticals & Biotechnology
79.1% of portfolio
📋 What Happened This Month Among existing holdings, Fortis Healthcare Limited saw the biggest increase — now at 4.79% of the portfolio. Sun Pharmaceutical Industries Limited was trimmed the most, now at 19.05%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 79.1%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Feb 2026 Mar 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 78.1% 79.4% +1.3%
Healthcare Services 21.8% 20.6% -1.3%
Mar 2026 Apr 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 79.4% 79.1% -0.3%
Healthcare Services 20.6% 20.8% +0.3%
Biggest Add
Fortis Healthcare Limited
+0.46% · now 4.79%
Biggest Trim
Sun Pharmaceutical Industries Limited
-0.39% · now 19.05%

What Changed?

Comparing Mar 2026 → Apr 2026

Mar 2026 Apr 2026
↑ 10 Increased ↓ 10 Decreased
#StockSectorMar 2026Apr 2026Change
1
Fortis Healthcare Limited
₹64.97 L
Healthcare Services 4.33% 4.79% +0.46%
2
Divi's Laboratories Limited
₹1.12 Cr
Pharmaceuticals & Biotechnology 7.89% 8.22% +0.33%
3
Glenmark Pharmaceuticals Limited
₹48.97 L
Pharmaceuticals & Biotechnology 3.35% 3.61% +0.26%
4
Laurus Labs Limited
₹57.83 L
Pharmaceuticals & Biotechnology 4.03% 4.26% +0.23%
5
Mankind Pharma Limited
₹34.35 L
Pharmaceuticals & Biotechnology 2.37% 2.53% +0.16%
6
Cipla Limited
₹99.50 L
Pharmaceuticals & Biotechnology 7.20% 7.33% +0.13%
7
Piramal Pharma Limited
₹13.55 L
Pharmaceuticals & Biotechnology 0.88% 1.00% +0.12%
8
Syngene International Limited
₹12.00 L
Healthcare Services 0.77% 0.88% +0.11%
9
Aurobindo Pharma Limited
₹52.47 L
Pharmaceuticals & Biotechnology 3.81% 3.87% +0.06%
10
Dr. Reddy's Laboratories Limited
₹1.09 Cr
Pharmaceuticals & Biotechnology 7.99% 8.02% +0.03%
#StockSectorMar 2026Apr 2026Change
1
Sun Pharmaceutical Industries Limited
₹2.59 Cr
Pharmaceuticals & Biotechnology 19.44% 19.05% -0.39%
2
Lupin Limited
₹75.52 L
Pharmaceuticals & Biotechnology 5.86% 5.56% -0.30%
3
Torrent Pharmaceuticals Limited
₹59.14 L
Pharmaceuticals & Biotechnology 4.61% 4.36% -0.25%
4
IPCA Laboratories Limited
₹28.70 L
Pharmaceuticals & Biotechnology 2.32% 2.11% -0.21%
5
Apollo Hospitals Enterprise Limited
₹1.06 Cr
Healthcare Services 7.97% 7.82% -0.15%
6
Biocon Limited
₹34.67 L
Pharmaceuticals & Biotechnology 2.69% 2.55% -0.14%
7
Max Healthcare Institute Limited
₹99.77 L
Healthcare Services 7.48% 7.35% -0.13%
8
Abbott India Limited
₹17.30 L
Pharmaceuticals & Biotechnology 1.40% 1.27% -0.13%
9
Alkem Laboratories Limited
₹42.71 L
Pharmaceuticals & Biotechnology 3.24% 3.15% -0.09%
10
Zydus Lifesciences Limited
₹30.15 L
Pharmaceuticals & Biotechnology 2.28% 2.22% -0.06%

Full Portfolio

20 stocks — Apr 2026

# Stock Sector Cap Weight & Value
1
₹2.59 Cr
Pharmaceuticals & Biotechnology
19.05%
2
₹1.12 Cr
Pharmaceuticals & Biotechnology
8.22%
3
₹1.09 Cr
Pharmaceuticals & Biotechnology
8.02%
4
₹1.06 Cr
Healthcare Services
7.82%
5
₹99.77 L
Healthcare Services
7.35%
6
₹99.50 L
Pharmaceuticals & Biotechnology
7.33%
7
₹75.52 L
Pharmaceuticals & Biotechnology
5.56%
8
₹64.97 L
Healthcare Services
4.79%
9
₹59.14 L
Pharmaceuticals & Biotechnology
4.36%
10
₹57.83 L
Pharmaceuticals & Biotechnology
4.26%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 DSP Mutual Fund — Portfolio & Holdings
See all funds managed by DSP Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.